Assignee: BIOVAIL LABORATORIES INTERNATIONAL S.R.L. Primary Class: 424/465 Other Classes: 424/484, 514/469 International Classes: A61K31/343; A61K9/00; A61K9/22; A61P25/22; A61P25/24 View Patent Images: Download
Assignee: Biovail Laboratories International SRL Primary Class: 424/465 Other Classes: 424/458 International Classes: A61J1/03; A61K9/20; A61K9/00; A61K9/14; A61K9/16; A61K9/48; A61K31/138; A61K31/366; A61K31/426; A61K31/437; A61K31/4525; A61K45/00; A61K47/02; A61K47...
A method of treating or preventing myocardial ischemia in a patient in need thereof comprising administration of a controlled-release Galenical preparation of pharmaceutically accep
The invention provides a composition useful for making oral dosage forms capable of dissolving in the mouth in less than 40 seconds without the need for a conventional super disintegrant and having a friability of less than 1%; wherein the composition includes liquiflash particles and an excipient...